ECOG-ACRIN 1308: Commentary on a Negative Phase II Trial

Affiliations

Comment

Adam S Garden et al. J Clin Oncol. 2017.

. 2017 Jun 10;35(17):1969-1970.

doi: 10.1200/JCO.2017.72.5085. Epub 2017 Apr 21.

¹ Adam S. Garden and Pierre Blanchard, The University of Texas MD Anderson Cancer Center, Houston, TX.

No abstract available

Comment in

Reply to A. Garden et al.
Marur S, Li S, Cmelak A, Burtness B. Marur S, et al. J Clin Oncol. 2017 Jun 10;35(17):1970-1971. doi: 10.1200/JCO.2017.72.8279. Epub 2017 Apr 21. J Clin Oncol. 2017. PMID: 28430530 No abstract available.

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
Marur S, Li S, Cmelak AJ, Gillison ML, Zhao WJ, Ferris RL, Westra WH, Gilbert J, Bauman JE, Wagner LI, Trevarthen DR, Balkrishna J, Murphy BA, Agrawal N, Colevas AD, Chung CH, Burtness B. Marur S, et al. J Clin Oncol. 2017 Feb 10;35(5):490-497. doi: 10.1200/JCO.2016.68.3300. Epub 2016 Dec 28. J Clin Oncol. 2017. PMID: 28029303 Free PMC article. Clinical Trial.